Ticket prices plunge minus Caitlin Clark for Fever road games
May 29 - The WNBA and several of its teams and broadcast partners are about to feel the impact of Caitlin Clark not being on the floor.
Clark is expected to miss at least four games with a left quadriceps strain. The news comes on the heels of 2.22 million viewers tuning in to see Clark's Indiana Fever take on the defending champion New York Liberty on Saturday -- the second-highest ratings in history for a WNBA game on CBS. The game peaked at 3.24 million viewers.
No. 1 on the list? The Fever's win over the Chicago Sky and Clark rival Angel Reese last June that drew 2.25 million viewers. The top two WNBA game ratings of all time on any network have also involved Clark -- 2.7 million on ABC for the Fever's home game against the Sky on May 17 and 2.3 million for the Fever at Sky on June 23, 2024.
The league's broadcast partners will no doubt feel a hit without Clark. Over the next four games, Indiana will be featured twice on NBA TV, once on CBS and once on Ion.
The massive impact at the gate is already being felt.
Tickets for the Fever's game against the Washington Mystics on Wednesday were down 47 percent since the announcement of Clark's injury, according to TickPick as reported by Front Office Sports. That contest was moved from the Mystics' usual home venue, 4,200-seat CareFirst Arena in Washington, to 11,614-seat CFG Bank Arena in Baltimore to accommodate the interest in an expected visit by Clark.
The get-in price for Indiana's trip to the Sky on June 7 fell 71 percent. That game was moved from 10,387-seat Wintrust Arena to 20,917-seat United Center in anticipation of Clark's participation.
The Fever are more concerned about Clark's long-term health than they are about television ratings and road attendance.
"For me, it's maintaining perspective," Indiana coach Stephanie White said. "It's making sure that we address this in a way that doesn't affect long-term. That we take care of it, don't over-push, don't over-exert. Making sure that we take the long-game approach to this so that we're not having lingering issues throughout the course of the season."
Clark is averaging 19 points, 9.3 assists and six rebounds per game across four outings this season. The injury occurred sometime during the 90-88 home loss to the Liberty and will lead to the first non-exhibition games Clark has ever missed in the WNBA or in college.
The initial timeframe for Clark's injury could see her return in time for Indiana's game at Atlanta on June 10 or against New York on June 14, which is slated to be televised on ABC. The Fever's game against Las Vegas on June 22 will be on ESPN.
--Field Level Media
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
23 minutes ago
- The Sun
We're swingers, people think it's all fun and games, but it's so expensive and there are loads of rules to follow
MANY people see swinging as a free-for-all where you can do whatever you want between the sheets with whoever you want. But Belle and Jase, who have been swinging for years, reveal swinging isn't all fun and games. 2 Taking to social media, the US couple gave a glimpse as to what full-time swinging is really like. The couple say they have dabbled in swinging house parties, cruises and even hotel takeovers. And while on these sex excursions, the couple have found it has some downsides. Taking to their podcast 4ourplay, Jase asked Belle: "What is one downside to swinging?" And Belle didn't hold back as she revealed the lifestyle was very pricey. She said: "I think a lot of people don't know that it's super expensive to be in this type of lifestyle. "So not only going to the clubs, having to pay membership to be a part of it and paying door fees to get in, that's just to a club. Hotel takeovers are really expensive." Jase added: "If you're going to try a vacation, it's like way more expensive than a normal vacation because of the type of activities that they allow there and how they have to charter the whole thing out." They also said dressing up for the events can quickly add up as well as keeping groomed. The couple also revealed that there were lots of boundaries and rules put in place for swinging. I'm a Mormon wife and 'soft swinger' but I fear being thrown out of the church The two have their own set of rules and Belle revealed a few they keep to when sleeping with other people. She said protection was an absolute must, and that the pair never go off on their own, preferring to stay together while they 'play'. And when they are playing with others, the two have vowed not to get too 'intimate' and refuse to cuddle with the people they have intercourse with. Jase added: "We don't do any intimate cuddling like that. That personally feels too intimate for us and we don't do any pictures, videos during the play sessions." What is Swinging? SWINGING, also known as partner swapping, is a sexual activity where partners in a committed relationship engage in sexual activities with other people. All parties involved must give explicit and enthusiastic consent. Open and honest communication between partners is crucial. Many swingers engage with a community or attend events specifically for swinging. Such activity can enhance intimacy and trust within the primary relationship. It provides an opportunity to explore sexual fantasies and desires. But it is not suitable for every relationship and requires a strong foundation of trust. Jealousy and emotional challenges may arise and need to be managed. Clips of the podcast have gone viral on its TikTok account @ 4ourplaypodcast with over 579k views. People were quick to share their thoughts on swinging. One person wrote: "Omg I thought I was the only one who thought this. I'm a unicorn and WHEWWWW swinging alone is expensive as hell." Another commented: 'It CAN be expensive, but you don't have to be rich." "Yes, it is but it's totally worth it," penned a third. Meanwhile a fourth said: "Sooooo expensive."
Sky News
24 minutes ago
- Sky News
Man killed after waste container he was sleeping in was emptied into bin lorry
A man has been killed and another was injured in the US after a waste container they were sleeping in was emptied into a bin lorry. The two men had been in the large bin outside a shopping centre on Long Island in New York on Thursday, according to Suffolk County police. Someone spotted a person inside the back of the lorry when the truck stopped outside a school nearly six miles away around 6.30am. The person was removed and taken to hospital to be treated for a leg injury. The other man was pronounced dead at the scene. Police said the medical examiner's office will determine the cause of death, but they do not believe the man was dead before he ended up in the lorry. Officers did not identify either man, but said they were believed to have both been sleeping in the container at the time. School officials sent a message to parents to reassure them that the emergency response at the school was "completely unrelated" to the school, adding there was no threat to students or staff and classes were operating as normal.
Reuters
31 minutes ago
- Reuters
Regeneron shares slide on mixed trial data on smoker's lung drug
May 30 (Reuters) - Regeneron (REGN.O), opens new tab shares fell nearly 13% before the bell on Friday after its experimental drug for patients with a type of lung condition commonly called "smoker's lung" failed a late-stage trial, although it succeeded in another. Regeneron and partner Sanofi ( opens new tab were studying the potential blockbuster drug, itepekimab, as a treatment for chronic obstructive pulmonary disease (COPD) in adult former smokers. The condition has limited treatment options and the drug was expected to target a broader patient population compared to Regeneron and Sanofi's blockbuster Dupixent, which is also approved for the condition. But after Friday's data, Barclays analyst Emily Field said Dupixent is likely to remain the first choice for doctors. GSK's (GSK.L), opens new tab Nucala, approved recently for COPD, is also a blockbuster drug. Nearly 16 million U.S. adults suffer from COPD, according to government data. Regeneron's shares, which have already fallen 15% this year, were trading at $530 in premarket trading. The company has a market capitalization of $65.36 billion. The company's itepekimab showed a significant reduction in exacerbations or flare-ups in the condition by 27% compared to placebo at 52 weeks in a 1,127-patient study. But the second study - which had enrolled fewer former smokers compared to the first - did not meet its goal although a benefit was seen earlier in the trial. The experimental drug, which is being jointly developed by Regeneron and Sanofi, binds to and inhibits interleukin-33, a type of protein that causes inflammation in COPD. COPD is a common lung disease causing restricted airflow and breathing problems. It typically affects smokers, but can also be caused by pollutants. Sanofi and Regeneron are assessing the data and will discuss with regulatory authorities to evaluate their next steps, the companies said. Regeneron's price to earnings ratio, a common benchmark for valuing stocks, was 16.15, compared with 13.62 for Gilead (GILD.O), opens new tab and 7.29 for Bristol Myers Squibb (BMY.N), opens new tab.
